{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:19:21Z","timestamp":1790997561405,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jiangsu's Mass Entrepreneurship and Innovation Program and the Large Instruments Open Foundation of Nantong University","award":["KJD350002"],"award-info":[{"award-number":["KJD350002"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1112258"],"award-info":[{"award-number":["1112258"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic reprogramming in cancer cells plays a crucial role in cancer development, metastasis and invasion. Cancer cells have a unique metabolism profile that could switch between glycolysis and oxidative phosphorylation (OXPHOS) in order to satisfy a higher proliferative rate and enable survival in tumor microenvironment. Although dietary-based cancer starvation therapy has shown some positive outcomes for cancer treatment, it is difficult for patients to persist for a long time due to the adverse effects. Here in this study, we developed a specific M1 macrophage-derived membrane-based drug delivery system for breast cancer treatment. Both metformin and 3-Bromopyruvate were loaded into the engineered cell membrane-based biomimetic carriers (Met-3BP-Lip@M1) for the shutdown of energy metabolism in cancer cells via simultaneous inhibition of both glycolysis and oxygen consumption. The in vitro studies showed that Met-3BP-Lip@M1 had excellent cancer cell uptake and enhanced cancer cell apoptosis via cell cycle arrest. Our results also demonstrated that this novel biomimetic nanomedicine-based cancer starvation therapy synergistically improved the therapeutic efficiency against breast cancer cells by blocking energy metabolic pathways, which resulted in a significant reduction of cancer cell proliferation, 3D tumor spheroid growth as well as in vivo tumor growth.<\/jats:p>","DOI":"10.1186\/s12951-023-02061-4","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T10:01:58Z","timestamp":1693044118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Biomimetic nanovesicle co-delivery system impairs energy metabolism for cancer treatment"],"prefix":"10.1186","volume":"21","author":[{"given":"Yongmei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,26]]},"reference":[{"issue":"3","key":"2061_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"4","key":"2061_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrc2817","volume":"10","author":"DA Tennant","year":"2010","unstructured":"Tennant DA, Dur\u00e1n RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer. 2010;10(4):267\u201377.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2061_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12957-016-0769-9","volume":"14","author":"C Li","year":"2016","unstructured":"Li C, Zhang G, Zhao L, Ma Z, Chen H. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer. World J Surg Oncol. 2016;14(1):15. https:\/\/doi.org\/10.1186\/s12957-016-0769-9.","journal-title":"World J Surg Oncol"},{"issue":"6","key":"2061_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.2174\/1568026618666180523111351","volume":"18","author":"NS Akins","year":"2018","unstructured":"Akins NS, Nielson TC, Le HV. Inhibition of glycolysis and glutaminolysis: an emerging drug discovery approach to combat cancer. Curr Top Med Chem. 2018;18(6):494\u2013504. https:\/\/doi.org\/10.2174\/1568026618666180523111351.","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"2061_CR5","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ccell.2019.03.007","volume":"35","author":"M Elgendy","year":"2019","unstructured":"Elgendy M, Cir\u00f2 M, Hosseini A, Weiszmann J, Mazzarella L, Ferrari E, Cazzoli R, Curigliano G, DeCensi A, Bonanni B, et al. Combination of hypoglycemia and metformin impairs tumor metabolic plasticity and growth by modulating the PP2A-GSK3\u03b2-MCL-1 axis. Cancer Cell. 2019;35(5):798-815.e795. https:\/\/doi.org\/10.1016\/j.ccell.2019.03.007.","journal-title":"Cancer Cell"},{"issue":"9","key":"2061_CR6","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","volume":"60","author":"CJ Bailey","year":"2017","unstructured":"Bailey CJ. Metformin: historical overview. Diabetologia. 2017;60(9):1566\u201376. https:\/\/doi.org\/10.1007\/s00125-017-4318-z.","journal-title":"Diabetologia"},{"issue":"12","key":"2061_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/biom9120846","volume":"9","author":"SM Samuel","year":"2019","unstructured":"Samuel SM, Varghese E, Kubatka P, Triggle CR, B\u00fcsselberg D. Metformin: the answer to cancer in a flower? Current knowledge and future prospects of metformin as an anti-cancer agent in breast cancer. Biomolecules. 2019;9(12):846. https:\/\/doi.org\/10.3390\/biom9120846.","journal-title":"Biomolecules"},{"issue":"5","key":"2061_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ccell.2019.04.008","volume":"35","author":"M Momcilovic","year":"2019","unstructured":"Momcilovic M, Shackelford DB. Teaching an old drug new tricks. Cancer Cell. 2019;35(5):709\u201311. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.008.","journal-title":"Cancer Cell"},{"issue":"3","key":"2061_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1042\/bj20140620","volume":"462","author":"HR Bridges","year":"2014","unstructured":"Bridges HR, Jones AJ, Pollak MN, Hirst J. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. Biochem J. 2014;462(3):475\u201387. https:\/\/doi.org\/10.1042\/bj20140620.","journal-title":"Biochem J"},{"issue":"3","key":"2061_CR10","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.apsb.2022.10.023","volume":"13","author":"J Feng","year":"2023","unstructured":"Feng J, Lian Z, Xia X, Lu Y, Hu K, Zhang Y, Liu Y, Hu L, Yuan K, Sun Z, et al. Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer. Acta Pharm Sin B. 2023;13(3):1145\u201363.","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"2061_CR11","doi-asserted-by":"publisher","first-page":"107719","DOI":"10.1016\/j.cclet.2022.07.062","volume":"34","author":"Y Xu","year":"2023","unstructured":"Xu Y, Huang L, Bi Y, Song Q, Zhang M, Zhang L, Zhou T, Xing L, Jiang H. Dual inhibition of glucose uptake and energy supply synergistically restrains the growth and metastasis of breast cancer. Chin Chem Lett. 2023;34(4):107719.","journal-title":"Chin Chem Lett"},{"issue":"34","key":"2061_CR12","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","volume":"25","author":"H Pelicano","year":"2006","unstructured":"Pelicano H, Martin DS, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene. 2006;25(34):4633\u2013446. https:\/\/doi.org\/10.1038\/sj.onc.1209597.","journal-title":"Oncogene"},{"key":"2061_CR13","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1186\/s12885-015-1850-4","volume":"15","author":"YM Attia","year":"2015","unstructured":"Attia YM, El-Abhar HS, Al Marzabani MM, Shouman SA. Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines. BMC Cancer. 2015;15:838. https:\/\/doi.org\/10.1186\/s12885-015-1850-4.","journal-title":"BMC Cancer"},{"issue":"3","key":"2061_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri3622","volume":"14","author":"PD Robbins","year":"2014","unstructured":"Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014;14(3):195\u2013208. https:\/\/doi.org\/10.1038\/nri3622.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2061_CR15","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3390\/pharmaceutics13091493","volume":"13","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Zheng Y, Zhu Y, Zhang Y, Zhu H, Liu T. M1 macrophage-derived exosomes loaded with gemcitabine and deferasirox against chemoresistant pancreatic cancer. Pharmaceutics. 2021;13(9):1493. https:\/\/doi.org\/10.3390\/pharmaceutics13091493.","journal-title":"Pharmaceutics"},{"issue":"1","key":"2061_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12951-022-01526-2","volume":"20","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zheng Y, Zhu Y, Li H, Zhu H, Liu T. Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer. J Nanobiotechnol. 2022;20(1):359. https:\/\/doi.org\/10.1186\/s12951-022-01526-2.","journal-title":"J Nanobiotechnol"},{"issue":"11","key":"2061_CR17","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.3390\/molecules28114498","volume":"28","author":"Y Yu","year":"2023","unstructured":"Yu Y, Fan P, Li J, Wang S. Preparation of biocompatible manganese selenium-based nanoparticles with antioxidant and catalytic functions. Molecules. 2023;28(11):4498.","journal-title":"Molecules"},{"key":"2061_CR18","doi-asserted-by":"publisher","first-page":"112677","DOI":"10.1016\/j.msec.2022.112677","volume":"135","author":"X Yang","year":"2022","unstructured":"Yang X, Wang S, Zhang X, Ye C, Wang S, An X. Development of PVA-based microsphere as a potential embolization agent. Biomater Adv. 2022;135:112677.","journal-title":"Biomater Adv"},{"issue":"8","key":"2061_CR19","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","volume":"10","author":"H Cao","year":"2016","unstructured":"Cao H, Dan Z, He X, Zhang Z, Yu H, Yin Q, Li Y. Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano. 2016;10(8):7738\u201348. https:\/\/doi.org\/10.1021\/acsnano.6b03148.","journal-title":"ACS Nano"},{"issue":"16","key":"2061_CR20","doi-asserted-by":"publisher","first-page":"1606209","DOI":"10.1002\/adma.201606209","volume":"29","author":"D Dehaini","year":"2017","unstructured":"Dehaini D, Wei X, Fang RH, Masson S, Angsantikul P, Luk BT, Zhang Y, Ying M, Jiang Y, Kroll AV, et al. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv Mater. 2017;29(16):1606209. https:\/\/doi.org\/10.1002\/adma.201606209.","journal-title":"Adv Mater"},{"issue":"7","key":"2061_CR21","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.ymthe.2017.02.007","volume":"25","author":"L Cheng","year":"2017","unstructured":"Cheng L, Wang Y, Huang L. Exosomes from M1-polarized macrophages potentiate the cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node. Mol Ther. 2017;25(7):1665\u201375. https:\/\/doi.org\/10.1016\/j.ymthe.2017.02.007.","journal-title":"Mol Ther"},{"key":"2061_CR22","doi-asserted-by":"publisher","first-page":"122844","DOI":"10.1016\/j.ijpharm.2023.122844","volume":"636","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Zheng Y, Zhu Y, Ding K, Zhou M, Liu T. Co-delivery of gemcitabine and triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer. Int J Pharm. 2023;636:122844. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122844.","journal-title":"Int J Pharm"},{"issue":"23","key":"2061_CR23","doi-asserted-by":"publisher","first-page":"6060","DOI":"10.1016\/j.biomaterials.2014.04.047","volume":"35","author":"T Liu","year":"2014","unstructured":"Liu T, Winter M, Thierry B. Quasi-spherical microwells on superhydrophobic substrates for long term culture of multicellular spheroids and high throughput assays. Biomaterials. 2014;35(23):6060\u20138. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.04.047.","journal-title":"Biomaterials"},{"issue":"1","key":"2061_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","volume":"20","author":"Y Wu","year":"2022","unstructured":"Wu Y, Wan S, Yang S, Hu H, Zhang C, Lai J, Zhou J, Chen W, Tang X, Luo J, et al. Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment. J Nanobiotechnol. 2022;20(1):542. https:\/\/doi.org\/10.1186\/s12951-022-01746-6.","journal-title":"J Nanobiotechnol"},{"key":"2061_CR25","doi-asserted-by":"publisher","first-page":"e02242","DOI":"10.7554\/eLife.02242","volume":"3","author":"WW Wheaton","year":"2014","unstructured":"Wheaton WW, Weinberg SE, Hamanaka RB, Soberanes S, Sullivan LB, Anso E, Glasauer A, Dufour E, Mutlu GM, Budigner GS, et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. Elife. 2014;3:e02242. https:\/\/doi.org\/10.7554\/eLife.02242.","journal-title":"Elife"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02061-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-02061-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02061-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T16:24:48Z","timestamp":1700497488000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-02061-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,26]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2061"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-02061-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,26]]},"assertion":[{"value":"14 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of Nantong University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors are consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"299"}}